For the Quarter Ending September 2025
North America
• In USA, the Boron Trifluoride Price Index rose by 8.94% quarter-over-quarter, driven by import competitiveness.
• The average Boron Trifluoride price for the quarter was approximately USD 8642.33/MT per market sources
• Boron Trifluoride Price Forecast indicates modest volatility with sequential monthly corrections and intermittent recovery phases
• Boron Trifluoride Production Cost Trend lifted by higher boric acid feedstock prices and logistic disruptions
• Boron Trifluoride Demand Outlook remains cautious despite semiconductor recovery, with buyers adopting wait-and-see procurement approaches
• The downstream semiconductor market in the USA experienced robust growth in Augus pressured the Boron Trifluoride Price Index.
• Export flows and freight volatility influenced competitiveness, while expensive Indian supplies intensified regional price competition
Why did the price of Boron Trifluoride change in September 2025 in North America?
• Elevated Chinese and Indian exports increased available supply, undermining domestic buying and pressuring prices further
• Logistical disruptions and port congestion intermittently delayed shipments, elevating cost uncertainty and supply timing risks
• Semiconductor sector recovery spurred sporadic ahead buying, offset by sustained destocking and tariff risk aversion
APAC
• In India, the Boron Trifluoride Price Index rose by 11.04% quarter-over-quarter due to export strength.
• The average Boron Trifluoride price for the quarter was approximately INR 808500/MT FOB JNPT, reflecting export-driven buying.
• Boron Trifluoride Spot Price firmed on ASEAN ahead-buying, supporting domestic Price Index and trade activity.
• Boron Trifluoride Production Cost Trend: lower boric acid eased costs, while logistics increased manufacturing expenses.
• Boron Trifluoride Demand Outlook strengthened from semiconductor restocking and ASEAN export orders amid tariff concerns.
• Boron Trifluoride Price Forecast anticipates modest volatility with seasonal corrections and restocking effects influencing pricing.
• Boron Trifluoride Price Index reflected tightened availability from monsoon disruptions, port congestion, and export commitments.
• Inventory and buyer ahead-buying influenced spot behavior, prompting sellers to defend margins in domestic markets.
Why did the price of Boron Trifluoride change in September 2025 in APAC?
• Robust export orders and semiconductor restocking elevated demand, leading to upward price pressure in September.
• Monsoon-related floods and port congestion constrained supply chains, increasing delivery delays and inventory shortages significantly.
• Feedstock boric acid price movements and tariff-related ahead-buying shifted production costs and buyer purchasing patterns.
Europe
• In Europe, the Boron Trifluoride Price Index rose by quarter-over-quarter, supported by pharmaceutical and semiconductor restocking activity
• Boron Trifluoride Price Forecast suggests moderate upside potential, contingent on feedstock stability and seasonal procurement cycles.
• Boron Trifluoride Production Cost Trend remained elevated due to rising boric acid prices and energy tariffs across Western Europe.
• Boron Trifluoride Demand Outlook was steady in pharmaceuticals and electronics, while chemical synthesis and polymer sectors showed mixed signals.
• Increased semiconductor-grade demand in Germany and the Netherlands supported the Boron Trifluoride Price Index in late Q3.
• Reduced Asian imports and tighter logistics across inland Europe sustained spot premiums and lifted regional competitiveness.
Why did the price of Boron Trifluoride change in September 2025 in Europe?
• Pharmaceutical and semiconductor restocking lifted demand, supporting the Price Index despite cautious procurement.
• Elevated feedstock and energy costs sustained production pressure, limiting downside flexibility for producers.
• Inland freight delays and reduced Asian supply tightened availability, prompting firm spot offers across key European terminals.
• Ample domestic supply and uninterrupted plant operations limited upward pressure on prices despite muted demand.
• Cheaper Asian imports and elevated inventories pressured local margins, while rising freight rates constrained trading.
• Downstream packaging off-season and cautious converter procurement reduced immediate demand, keeping price momentum subdued overall
For the Quarter Ending June 2025
North America
• Boron Trifluoride prices in the U.S. market posted an overall quarterly decline of 0.6% during Q2 2025, closing June at USD 7900/MT CFR Houston after falling by 1.3% in April, rising modestly by 1.3% in May, and then reversing again by 1.7% in June. The quarter was marked by inconsistent demand from key end-use sectors and volatile geopolitical trade dynamics.
• Why did the price of Boron Trifluoride change in July 2025 in North America?
• At the start of July, prices remained under pressure amid a continued low-demand environment and persistent import oversupply. Market participants remained cautious ahead of the anticipated August implementation of new tariffs by the Trump administration, further stifling forward procurement activity.
• The Boron Trifluoride Production Cost Trend in North America was relatively stable, though largely impacted by import pricing from China and India. While Chinese factories expanded production and resumed aggressive exports, shipping rates from Shanghai to Houston surged by over 20% in June. However, the high supply volumes offset these increased logistics costs, resulting in flat to softer landed costs.
• Boron Trifluoride Demand Outlook weakened throughout the quarter, with only a brief improvement in May driven by pharmaceutical restocking. Demand from the semiconductor and stainless steel sectors remained notably muted due to subdued downstream activity, weather-related disruptions, and growing macroeconomic uncertainty surrounding tariffs and global trade shifts.
• Export momentum of Boron Trifluoride to the U.S. surged in June, particularly from China, as production ramped up and trade routes normalized. However, this influx of cargo met limited demand, leading to an imbalance that exacerbated inventory pressures at U.S. ports and distribution centers.
• Domestic procurement in the United States remained highly conservative across Q2, with pharmaceutical firms maintaining baseline purchasing, while semiconductor-related inquiries fell sharply due to soft nickel demand and seasonal manufacturing slowdowns.
Asia-Pacific (APAC)
• Boron Trifluoride Price Index in APAC declined by 1.7% overall during Q2 2025, despite a rebound in June. Prices fell by 2.7% in April and 2.0% in May amid persistent oversupply and weakened domestic demand, before recovering in June due to a pickup in semiconductor sector demand and active export bookings from ASEAN markets.
• Why did the price of Boron Trifluoride change in July 2025 in India?
• In early July, prices remained stable as improved export demand from the semiconductor industry and strategic stockpiling offset cautious buying from India’s pharmaceutical sector. Logistical constraints from seasonal monsoon disruptions and shifting global trade policies limited sharp price movements.
• The Boron Trifluoride Production Cost Trend was mixed during the quarter—manufacturing costs eased on the back of falling Boric Acid and energy prices, yet supply-side challenges persisted due to monsoon-driven delays at Kandla and JNPT ports.
• Boron Trifluoride Demand Outlook remained soft overall through Q2, despite a slight improvement in June. Pharmaceutical consumption, particularly in chronic therapies, was steady but non-spectacular, while acute therapy demand remained sluggish. The semiconductor sector showed strength toward the quarter’s end, supporting hopes of a more sustained recovery.
• The export momentum of Boron Trifluoride fluctuated throughout the quarter. While April and May saw subdued overseas inquiries due to tariff concerns and policy unpredictability, June witnessed renewed demand from South Korea, Taiwan, and Japan as semiconductor exports surged. A temporary 90-day tariff pause between the U.S. and China helped stabilize forward bookings.
• Domestic procurement in India remained cautious during Q2, with buyers exercising restraint amid high inventories and limited incremental production growth.
Europe
• Boron Trifluoride prices in Europe registered a marginal quarterly decline during Q2 2025. Prices softened in April and May due to sustained demand weakness across downstream sectors, before stabilizing in June as seasonal construction activity picked up and pharmaceutical manufacturers increased procurement for Q3 production cycles.
• Why did the price of Boron Trifluoride change in July 2025 in Europe?
• Prices held largely stable in early July, supported by consistent pharmaceutical demand and supply-side constraints. Ongoing labor actions at major Northern European ports continued to pressure production and logistics, providing a floor beneath further price declines.
• The Boron Trifluoride Production Cost Trend in Europe remained elevated, primarily due to persistently high energy and labor costs. While raw material costs (like Boric Acid) saw some moderation, expensive logistics and tight operating margins at local facilities—particularly in Germany and France—kept average production costs firm.
• Boron Trifluoride Demand Outlook across Europe remained muted overall during Q2, especially in the pharmaceutical sector maintained steady offtake, particularly in Italy, Switzerland, and Germany, where domestic API synthesis supported stable consumption patterns.
• Export momentum of Boron Trifluoride from Europe remained subdued, as domestic producers prioritized internal demand and dealt with tightening environmental regulations.
• Domestic procurement in Europe was characterized by short-term, need-based buying, with end users avoiding large forward contracts due to economic uncertainty and fluctuating raw material price outlooks. Regulatory scrutiny surrounding emissions and product safety also delayed some purchase orders, adding friction to an already cautious market environment.
For the Quarter Ending March 2025
North America
Boron Trifluoride prices in the USA experienced significant fluctuations throughout Q1 2025, characterized by an initial downturn, followed by a recovery, and a subsequent decline in March. In January, the market sentiment was subdued, driven by substantial inventory surplus due to weak demand, which compelled sellers to reduce prices.
However, the pharmaceutical sector's growing investments stimulated demand, particularly concerning drug formulation, leading to a bullish price trend in February as supply constraints and stockpiling behavior emerged in response to anticipated price hikes.
Despite this peak, March revealed bearish price dynamics, with a considerable decline attributed to abundant inventories and cautious market sentiment amid tariff uncertainties. Seller hesitance resulted in reduced price expectations as buyers opted for immediate replenishment rather than larger orders, dampening trading activity. Nevertheless, consistent demand from the pharmaceutical industry remained a stabilizing factor, albeit overshadowed by procurement hesitance linked to the impending tariff on imported pharmaceuticals. Overall, although Q1 2025 showcased price variability, strong underlying demand in the pharmaceutical sector has reinforced the fundamental role of Boron Trifluoride, ensuring its continuous market relevance.
APAC
In Q1 2025, the price trend for Boron Trifluoride in the APAC region, particularly India exhibited notable fluctuations influenced by supply dynamics and market sentiment. January started with a bearish trend as prices declined due to subdued buyer appetite and ample inventories. Low trading volumes highlighted hesitance among buyers, significantly impacting seller pricing strategies.
However, February marked a recovery phase with a bullish trend driven by constrained supply and robust demand from the pharmaceutical sector. Limited availability and low production rates compelled sellers to raise prices amid seasonal stocking behaviors, as buyers anticipated further price hikes.
March saw a return to bearish conditions, with prices declining due to surplus inventories and cautious sentiment prevalent among sellers exacerbated by tariff uncertainties. Despite a negative year-over-year demand outlook, the pharmaceutical sector showed positive momentum, supported by a significant increase in funding, which underscored the continued necessity for Boron Trifluoride in drug synthesis.
Overall, Q1 2025 reflected a volatile pricing landscape, characterized by interactions between supply-demand shifts and external economic pressures.
Europe
In Q1 2025, the price trend for Boron Trifluoride in Germany demonstrated a steady yet marginally declining pattern, as evidenced by the pricing trend for the quarter. A similar trend was observed throughout the quarter.
This stability in the Boron Trifluoride market was largely influenced by stable demand from the pharmaceutical sector, where Boron Trifluoride played a crucial role in API synthesis, supported by ongoing regulatory changes driving increased clinical trials and drug formulation activities.
Manufacturing conditions remained robust, despite external pressures such as rising feedstock costs, demonstrating the effectiveness of domestic producers' inventory management to mitigate price volatility. Regulatory frameworks, such as the EU Health Technology Assessment Regulation and Clinical Trials Regulation transition, contributed to sustained demand, although concerns lingered regarding future competitiveness against lower-cost production in countries like the U.S. and China.
Overall, the combination of a balanced supply-demand dynamic ensured that while prices slightly dipped, market stability remained intact, reflecting resilience amid regulatory and competitive challenges in the pharmaceutical industry, and consequently the Boron Trifluoride market.
For the Quarter Ending December 2024
North America
The North American Boron Trifluoride market during Q4 2024 experienced a volatile price trend, shifting from an increase in October to declines in November and December. This volatility stemmed from a confluence of factors: surging demand for semiconductors, particularly in AI, coupled with supply chain constraints; fluctuations in the pharmaceutical sector; macroeconomic pressures such as inflation and interest rates; and finally, the typical year-end destocking activities.
Boron Trifluoride prices rose in October due to increased demand for semiconductors, primarily driven by limited supply from Taiwan despite production expansion efforts. Simultaneously, strong performance in the pharmaceutical sector further boosted demand. The US government's subsidy to TSMC for semiconductor production in Arizona is expected to further increase demand in the long term.
However, prices declined in November, due to softened demand from the pharmaceutical and healthcare sectors. Inflationary concerns, high interest rates, and a stronger US dollar contributed to this downward pressure. Easing logistical constraints also facilitated smoother supply chains.
In December, prices experienced a significant 8% drop due to aggressive year-end destocking, compounded by existing oversupply from pre-holiday purchases. Weak manufacturing demand, indicated by falling new orders and production, further reduced Boron Trifluoride consumption.
Europe
The European Boron Trifluoride market experienced a net downward price trend in Q4 2024. While October saw a potential upward blip due to increased consumer confidence and supply chain issues, the subsequent months showed a stronger downward trend driven by weaker economic conditions, reduced pharmaceutical demand, and increased price competition.
Increased consumer confidence, driven by improved business morale and interest rate cuts, boosted overall spending and investment, potentially increasing demand for Boron Trifluoride dependent pharmaceutical production. Supply chain constraints also exerted upward pressure in October.
However, November saw bearish trend in prices. Weak end-sector demand, fading inflation concerns, and reduced energy prices all contributed to lower costs, which were passed on to consumers. The sharp decline in Eurozone business activity, particularly in Germany, further indicates reduced demand for pharmaceuticals and, consequently, Boron Trifluoride. Well-maintained inventories also facilitated price competition.
The general economic slowdown and reduced consumer spending in the Eurozone in December, negatively impacted the demand for pharmaceuticals, indirectly impacting Boron Trifluoride demand and prices. Year-end destocking in these sectors exacerbated this downward trend.
APAC
The Boron Trifluoride market in the APAC region during Q4 2024 exhibited a volatile price trend. This volatility was primarily driven by fluctuating demand within the pharmaceutical sector. India, serving as a key market indicator for the region, played a significant role in driving these trends.
While October saw a price increase fueled by strong pharmaceutical growth, November and December witnessed price declines due to weakened demand, increased supply, and year-end destocking.
The performance of the pharmaceutical sector, particularly in India, was a primary driver of Boron Trifluoride demand. Growth, new product launches, and price changes significantly influenced the prices. Rising inflation and a slowdown in the manufacturing sector also contributed to reduced consumer spending and dampened demand for Boron Trifluoride. Moreover, intense competition within the pharmaceutical market exerted downward pressure on prices in November and December. While supply remained relatively stable throughout the quarter, pre-holiday oversupply and year-end destocking significantly affected prices. Year-end destocking played a crucial role in the decline in Boron Trifluoride prices.
